Atinum Partners logo

Atinum Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Atinum Partners, operating as Atinum Investment, is a prominent venture capital firm headquartered in Seoul, South Korea. Established in 1988, the firm has cultivated a strong reputation for its strategic investments in growth-stage companies. Atinum Investment is a significant player in the South Korean startup ecosystem, providing essential capital and strategic support to help innovative businesses achieve their scaling objectives across various high-potential industries.

The firm's investment strategy primarily focuses on growth-stage startups within the IT, biotech, and healthcare sectors, with additional interests in new materials and components. Atinum Investment is recognized for its substantial capital commitments, typically deploying first cheques that range from approximately $2.5 million to $8.4 million. This approach allows them to secure meaningful equity stakes and provide the robust financial backing necessary for companies transitioning from initial development to significant market expansion and operational maturity.

Atinum Investment has built an impressive portfolio, having invested in over 200 companies since its founding, and has led 39 funding rounds, according to Crunchbase. The firm also boasts a strong track record of successful exits, with 30 reported exits, underscoring its capability to generate substantial returns for its limited partners. In 2021, Atinum Investment notably closed a new fund totaling 100 billion Korean Won (approximately $84 million USD), further enhancing its capacity to support large-scale growth initiatives and reinforce its position as a leading investor in the region.

Investor Profile

Atinum Partners has backed more than 49 startups, with 13 new investments in the last 12 months alone. The firm has led 11 rounds, about 22% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in South Korea, United States, Singapore.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Biotechnology.
  • Led 5 rounds in the past year.
  • Typical check size: $2.5M – $8.4M.

Stage Focus

  • Series B (27%)
  • Series A (27%)
  • Series C (16%)
  • Seed (14%)
  • Series D (8%)
  • Series E (4%)
  • Series Unknown (4%)

Country Focus

  • South Korea (49%)
  • United States (31%)
  • Singapore (12%)
  • Israel (4%)
  • Japan (4%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Biotechnology
  • Enterprise Software
  • Information Technology
  • Finance
  • Financial Services
  • Health Care
  • Machine Learning
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Atinum Partners frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 6
Altos Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
SBVA
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 4
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 4
Murex Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 7
Company K Partners
Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu
Co-Investments: 5
Stone Bridge Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Kakao Ventures
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 5
InterVest Co.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5

Which angels does Atinum Partners often collaborate with?

VB
North America, California, United States, San Francisco
Shared Deals: 1
AV
North America, New York, United States, New York
Shared Deals: 1
TK
North America, California, United States, Los Angeles
Shared Deals: 1
SC
North America, California, United States, San Francisco
Shared Deals: 1
AG
Europe, Berlin, Germany, Berlin
Shared Deals: 1
MH
North America, California, United States, San Francisco
Shared Deals: 1
AS
North America, California, United States, San Francisco
Shared Deals: 2
ML
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Atinum Partners?

PineTree Therapeutics

Cambridge, Massachusetts, United States

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

BiotechnologyMedicalOncologyTherapeuticsWellness
Series BOct 28, 2025
Amount Raised: $47,000,000
MarqVision

Los Angeles, California, United States

MarqVision provides an AI-powered managed service platform to help brands remove counterfeits from online marketplaces.

Artificial Intelligence (AI)B2BEnterprise SoftwareIntellectual PropertySaaS
Series BSep 15, 2025
Amount Raised: $48,000,000
Money Walk

Seoul, Seoul-t'ukpyolsi, South Korea

Money Walk is a novel pedometer program that allows users to earn money simply by walking.

Health CareWellness
Series ASep 2, 2025
Amount Raised: $12,942,810
Nex Eye

Seoul, Seoul-t'ukpyolsi, South Korea

Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.

MedicalOncologyPharmaceutical
Series BAug 13, 2025
Amount Raised: $44,310,374
Law&Company

Seoul, Seoul-t'ukpyolsi, South Korea

Law&Company provide LawTalk service to solve information asymmetry and illegal legal broker of Korean legal market.

Information ServicesLaw EnforcementLegalLegal Tech
Series CJul 15, 2025
Amount Raised: $36,206,333
Subtle Medical

Menlo Park, California, United States

Subtle Medical provides AI-powered technology for medical imaging.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedical
Series UnknownJul 9, 2025
MADDE

Seoul, Seoul-t'ukpyolsi, South Korea

MADDE specializes in three-dimensional (3D) printing technology.

3D PrintingTechnical Support
Series AApr 15, 2025
Amount Raised: $7,700,411
MOVIN

Daejeon, Taejon-jikhalsi, South Korea

Moovin offers real-time markerless motion capture technology that does not require any additional hardware.

Information ServicesInformation TechnologySoftware
SeedMar 12, 2025
Amount Raised: $2,755,483
Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
CLO Virtual Fashion

Seoul, Seoul-t'ukpyolsi, South Korea

CLO Virtual Fashion provides a 3D fashion design software that simulates garments for better visualization in the fashion industry.

3D TechnologyAugmented RealityEnterprise SoftwareFashionRetail TechnologyVirtual Reality
Series CDec 16, 2024
Amount Raised: $34,818,942